Retatrutide vs Ozempic: Lilly’s triple-acting drug doubled weight loss in a head-to-head trial
MH
By Maren Holt · Senior Reporter, GLP-1
Oct 28 13:47 ETSource: Nacionale
From the source
Read at nacionale.comRetatrutide vs Ozempic: Lilly’s triple-acting drug doubled weight loss in a head-to-head trial
